By Ryan Davis and Mark Payne (February 8, 2024, 10:46 PM EST) — A Biden administration proposal aiming to lower drug prices by using the government’s authority to override patents for products developed with federal funding has drawn fierce pushback from drugmakers, universities and others who say the plan will hinder innovation….